Resources

Effect of Clozapine on Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Psychiatric Symptoms: A Series of Three Cases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465601/

Learn more
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705619/

Learn more
Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783555/

Learn more
GABAA receptor autoimmunity February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/

Learn more
Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624087/

Learn more
New-Onset Refractory Status Epilepticus with Underlying Autoimmune Etiology: a Case Report February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223986/

Learn more
Hashimoto’s encephalopathy: Follow-up data from neuropsychology, lumbar puncture, and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745505/

Learn more
Fatigue, Sleep, and Autoimmune and Related Disorders February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691096/

Learn more
Severe relapse of anti-NMDA receptor encephalitis 5 years after initial symptom onset February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661405/

Learn more
Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649545/

Learn more